Not skeptical on the science. Maybe I should change my name to Murphy. It was just the time it took to get the Phase 2 -201 trial underway, not to mention PBT2 gathering dust in someone's desk draw, that has shaken my confidence, but with the BioMuse study, along with results from both the -201 and -202 trials it's taking a bit for my confidence to return. I still have nightmares over PBT2, that was my initial big hope for this company, even though it was lower down the priority list.
ATH Price at posting:
0.9¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)